Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Bernard J, Weil M, Boiron M, Jacquillat C, Flandrin G, Gemon M-F. Acute promyelocytic leukemia: results of treatment by daunorubicin. Blood . 1973;41(4): 489-496 .

Blood (2016) 128 (14): 1779.

https://doi.org/10.1182/blood-2016-08-735084

Published: 2016

Journal Articles

Ellison RR, Holland JF, Weil M, et al. Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. Blood . 1968;32(4): 507-523 .

Blood (2016) 128 (7): 883.

https://doi.org/10.1182/blood-2016-06-725101

Published: 2016

Journal Articles

How to Treat Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Patients : Results on 86 Patients of the French BPDCN Network

Eve Poret, Chrystelle Vidal, Yohan Desbrosses, Fanny Angelot Delettre, Maider Pagadoy, Aurore Pugin, Louis Benazet, Franck Leroux, Elise Robert, Delphine Binda, Sabeha Biichle, Anne Roggy, PhDSTUDENT, Laure Philippe, MDcal student, Berengere Gruson, Anne-Claire Gac, Michel Maigre, Denis Caillot, Remy Gressin, MD, Pascal Turlure, MD, Anne-Sophie Michallet, MD, Lila Gilis, Veronique Dorvaux, Yazid Arkam, Caroline Bonmati, MD, Pierre Péterlin, Pierre-Simon Rohrlich, MD PhD, Thorsten Braun, MD PhD, jean-Valere Malfuson, Didier Bouscary, MDPhD, Eric Pujade-Lauraine, Felipe Suarez, MD PhD, Carole Soussain, MD, Etienne Lengliné, MD, Mathieu Puyade, MD, Tony Marchand, MD, Denis Guyotat, Bruno Lioure, MD, Christian Recher, MD, Damien Roos-Weil, Fabrice Jardin, Jean-Pierre Marolleau, Bernard Drenou, MD, Bernard Bonnotte, MD PhD, Sophie Dalac, Philippe Saas, PhD, Francine Garnache Ottou, PhD, Eric Deconinck

Blood (2015) 126 (23): 456.

https://doi.org/10.1182/blood.V126.23.456.456

Published: 2015

Journal Articles

Reduced Intensity Versus Myelo-Ablative Conditioning Regimen before Allogeneic Hematopoietic Stem Cell Transplantation for Blastic Plasmacytoid Dendritic Cell Neoplasm: A Retrospective Study of the French Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC)

Mathieu Leclerc, Régis Peffault de Latour, MD, Mauricette Michallet, MD PhD, Didier Blaise, Patrice Chevallier, MD PhD, Pierre-Simon Rohrlich, MD PhD, Pascal Turlure, MD, Stéphanie Nguyen, Fabrice Jardin, Ibrahim Yakoub-Agha, Leila Moukhtari, Nicole Raus, Sébastien Maury

Blood (2015) 126 (23): 3208.

https://doi.org/10.1182/blood.V126.23.3208.3208

Published: 2015

Journal Articles

Frequency and Risk Factors of Cord Graft Failure (CGF) Following Reduced Intensity Conditioning Haplo-Cord Hematopoietic Stem Cell Transplantation

Stephanie B. Tsai, MD MA, Hongtao Liu, MD PhD, Tsiporah B. Shore, MD, Michael R Bishop, MD, Melissa M. Cushing, MD, Yun Fan, MD, Usama Gergis, MD, Lucy A Godley, MD PhD, Justin Kline, MD, Richard A. Larson, Guadalupe G. Martinez, BS, Sebastian Mayer, MD, Olatoyosi Odenike, MD, Wendy Stock, MD, Amittha Wickrema, PhD, Koen van Besien, MD PhD, Andrew S. Artz, MD MS

Blood (2014) 124 (21): 2463.

https://doi.org/10.1182/blood.V124.21.2463.2463

Published: 2014

Journal Articles

Redefinition of Hypereosinophilic Disorders Based on an Analysis of 28 Cases of FIP1 L1-PDGFRA Negative Persistent Unexplained Eosinophilia (PUE) with Eosinophil End-Organ Damage (EEOD).

Finella Brito-Babapulle, Nicholas C.P. Cross

Blood (2007) 110 (11): 3310.

https://doi.org/10.1182/blood.V110.11.3310.3310

Published: 2007

NARROW

Bernard J, Weil M, Boiron M, Jacquillat C, Flandrin G, Gemon M-F. Acute promyelocytic leukemia: results of treatment by daunorubicin. Blood . 1973;41(4): 489-496 .

Ellison RR, Holland JF, Weil M, et al. Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. Blood . 1968;32(4): 507-523 .

How to Treat Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Patients : Results on 86 Patients of the French BPDCN Network

Reduced Intensity Versus Myelo-Ablative Conditioning Regimen before Allogeneic Hematopoietic Stem Cell Transplantation for Blastic Plasmacytoid Dendritic Cell Neoplasm: A Retrospective Study of the French Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC)

Frequency and Risk Factors of Cord Graft Failure (CGF) Following Reduced Intensity Conditioning Haplo-Cord Hematopoietic Stem Cell Transplantation

Redefinition of Hypereosinophilic Disorders Based on an Analysis of 28 Cases of FIP1 L1-PDGFRA Negative Persistent Unexplained Eosinophilia (PUE) with Eosinophil End-Organ Damage (EEOD).

Email alerts

ASH Publications

American Society of Hematology

Bernard J, Weil M, Boiron M, Jacquillat C, Flandrin G, Gemon M-F. Acute promyelocytic leukemia: results of treatment by daunorubicin. Blood . 1973;41(4): 489-496 .

Ellison RR, Holland JF, Weil M, et al. Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. Blood . 1968;32(4): 507-523 .

How to Treat Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Patients : Results on 86 Patients of the French BPDCN Network

Reduced Intensity Versus Myelo-Ablative Conditioning Regimen before Allogeneic Hematopoietic Stem Cell Transplantation for Blastic Plasmacytoid Dendritic Cell Neoplasm: A Retrospective Study of the French Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC)

Frequency and Risk Factors of Cord Graft Failure (CGF) Following Reduced Intensity Conditioning Haplo-Cord Hematopoietic Stem Cell Transplantation

Redefinition of Hypereosinophilic Disorders Based on an Analysis of 28 Cases of FIP1 L1-PDGFRA Negative Persistent Unexplained Eosinophilia (PUE) with Eosinophil End-Organ Damage (EEOD).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only